Identification of Hydroxylated Chlorinated Paraffins in Human Serum and Their Potential Metabolic Pathways
Environmental Science & Technology · 2025
DOI: 10.1021/acs.est.5c00091 ↗Kurz gefasst
Fachartikel in der Zeitschrift Environmental Science & Technology, 2025. Verfasst von Juntao Cui und 8 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Advanced Environmental Technology, Guangdong Key Laboratory of Environment Protection and Resource Utilization, Guangzhou Ins…. Hauptthemen laut MEDLINE: Paraffin. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 54 Literaturangaben. Gefördert von: Science Fund for Creative Research Groups, Guangdong Provincial Applied Science and Technology Research and Development Program, National Natural Science Foundation of China.
Abstract (Originalsprache)
Short- and medium-chain chlorinated paraffins (SCCPs and MCCPs) are frequently detected in humans. However, information regarding their metabolites is still very limited. Herein, target analysis and halogenation-guided nontarget and suspect screening were conducted on serum samples using UHPLC-Orbitrap-HRMS. The median concentrations of SCCPs and MCCPs were 7.76 and 4.31 ng/mL, respectively. A series of hydroxylated chlorinated paraffins (OH-CPs) were tentatively identified with an estimated average concentration of 1.80 ng/mL, which was approximately 9.9% of the total SCCPs and MCCPs. A chlorine distribution shift was observed from chlorinated paraffins (CPs) dominated by Cl6 and Cl7 to OH-CPs dominated by Cl5, Cl6, and Cl4. In human liver cytochrome P450 (CYP) enzyme incubation assays, the CPs in commercial mixtures were mainly metabolized into OH-CPs with various carbon lengths and chlorine substituents. The results obtained from human serum and in vitro experiments suggested the oxidative metabolism of SCCPs and MCCPs in humans. The metabolic pathways were then comprehensively explored using a CP monomer (1,1,1,3,10,11-hexachloroundecane) incubated with the same CYP enzymes, demonstrating that CPs can be metabolized through successive oxidative dechlorination and direct hydroxylation, with subsequent oxidation to carboxylic acids. Further studies should focus on the long-term toxicity of OH-CPs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Advanced Environmental Technology, Guangdong Key Laboratory of Environment Protection and Resource Utilization, Guangzhou Institute of Geochemistry, Chinese Academy of Sciences, Guangzhou, Guangd…
- Department of Obstetrics and Gynaecology, Nanfang Hospital, Southern Medical University, Guangzhou 510515, People's Republic of China.
- University of Chinese Academy of Sciences, Beijing 100049, People's Republic of China.
- Institute of Environmental Pollution and Health, School of Environmental and Chemical Engineering, Shanghai University, Shanghai 200444, People's Republic of China.
ORCID-Profile: Juntao Cui, Guofa Ren, Jing An
Förderung
- Science Fund for Creative Research Groups
- Guangdong Provincial Applied Science and Technology Research and Development Program
- National Natural Science Foundation of China
Zitieren
APA
Cui, J., Hua, R., Wu, Y., Wang, H., Wang, D., Ren, G., An, J., Quan, S., & Yu, Z. (2025). Identification of Hydroxylated Chlorinated Paraffins in Human Serum and Their Potential Metabolic Pathways. Environmental Science & Technology. https://doi.org/10.1021/acs.est.5c00091
Vancouver
Cui J, Hua R, Wu Y, Wang H, Wang D, Ren G, et al. Identification of Hydroxylated Chlorinated Paraffins in Human Serum and Their Potential Metabolic Pathways. Environmental Science & Technology. 2025. doi:10.1021/acs.est.5c00091
BibTeX
@article{Cui2025,
author = {Cui, Juntao and Hua, Rui and Wu, Yang and Wang, Hua and Wang, Dian and Ren, Guofa and An, Jing and Quan, Song and Yu, Zhiqiang},
title = {Identification of Hydroxylated Chlorinated Paraffins in Human Serum and Their Potential Metabolic Pathways},
journal = {Environmental Science & Technology},
year = {2025},
doi = {10.1021/acs.est.5c00091}
}
EUVIMED